Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,845.20
-45.95 (-2.43%)
At close: May 22, 2026

BOM:524715 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
116,031102,68892,85746,23745,083
Short-Term Investments
209,33545,35753,71260,04144,695
Trading Asset Securities
-113,18344,33245,02236,771
Cash & Short-Term Investments
325,365261,227190,901151,300126,548
Cash Growth
24.55%36.84%26.17%19.56%32.33%
Accounts Receivable
155,097130,610112,602114,568105,035
Other Receivables
-2,9646,1884,1363,509
Receivables
155,624134,058119,440119,117110,243
Inventory
114,929107,593102,949109,68392,392
Prepaid Expenses
-3,7504,1353,7182,862
Other Current Assets
42,99419,61717,32515,01516,601
Total Current Assets
638,912526,245434,750398,833348,646
Property, Plant & Equipment
124,948112,703113,001113,537111,689
Long-Term Investments
37,89146,97764,41254,51749,592
Goodwill
98,33189,39485,69083,58065,913
Other Intangible Assets
135,46290,20587,33093,26861,918
Long-Term Accounts Receivable
---108.3193.7
Long-Term Deferred Tax Assets
40,46544,07641,03735,18928,496
Other Long-Term Assets
11,82711,37828,76928,39631,623
Total Assets
1,087,852921,006854,997807,436698,078
Accounts Payable
73,33861,84356,53356,81544,898
Accrued Expenses
-18,85616,88915,12714,833
Short-Term Debt
40,50418,67128,44459,5834,685
Current Portion of Long-Term Debt
---2,3962,323
Current Portion of Leases
1,8411,3681,2571,2811,078
Current Income Taxes Payable
13,5007,3324,1173,0871,756
Current Unearned Revenue
-1,3441,2651,5671,930
Other Current Liabilities
97,03872,52861,33959,214100,582
Total Current Liabilities
226,220181,942169,844199,070172,085
Long-Term Debt
312.625.213.3-2,299
Long-Term Leases
3,6163,5573,0235,5992,518
Long-Term Unearned Revenue
-3,7674,8875,6996,188
Pension & Post-Retirement Benefits
-4,5353,9973,2623,434
Long-Term Deferred Tax Liabilities
3,7801,9241,719316.9318.6
Other Long-Term Liabilities
15,125395.2253.7334.6575.4
Total Liabilities
249,055196,146183,737214,281187,417
Common Stock
2,3992,3992,3992,3992,399
Additional Paid-In Capital
-11,87411,87411,87411,874
Retained Earnings
-614,525537,452472,009412,363
Comprehensive Income & Other
833,30293,38284,94273,67153,476
Total Common Equity
835,701722,180636,668559,954480,112
Minority Interest
3,0972,67934,59233,20130,549
Shareholders' Equity
838,797724,860671,259593,155510,661
Total Liabilities & Equity
1,087,852921,006854,997807,436698,078
Total Debt
46,27323,62232,73768,85912,903
Net Cash (Debt)
279,092237,605158,16482,441113,645
Net Cash Growth
17.46%50.23%91.85%-27.46%99.57%
Net Cash Per Share
116.2199.0365.9234.3647.37
Filing Date Shares Outstanding
2,4022,3992,3992,3992,399
Total Common Shares Outstanding
2,4022,3992,3992,3992,399
Working Capital
412,692344,303264,906199,763176,562
Book Value Per Share
347.95300.99265.35233.38200.10
Tangible Book Value
601,909542,581463,648383,105352,282
Tangible Book Value Per Share
250.61226.14193.24159.67146.82
Land
-7,8568,1736,6766,448
Buildings
-65,66863,61061,39557,836
Machinery
-152,025146,265139,645132,031
Construction In Progress
-12,34311,0779,6347,975
Source: S&P Global Market Intelligence. Standard template. Financial Sources.